173 related articles for article (PubMed ID: 36533707)
21. Benign goiters requiring thyroidectomy as the signal for PTEN hamartoma tumor syndrome diagnosis.
Wang X; Moore C; Bao Y
Am J Med Genet A; 2023 Mar; 191(3):753-759. PubMed ID: 36453251
[TBL] [Abstract][Full Text] [Related]
22. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
23. Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome.
Drissen MMCM; Schieving JH; Schuurs-Hoeijmakers JHM; Vos JR; Hoogerbrugge N
Eur J Med Genet; 2021 Dec; 64(12):104364. PubMed ID: 34637944
[TBL] [Abstract][Full Text] [Related]
24. A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.
Pradella LM; Evangelisti C; Ligorio C; Ceccarelli C; Neri I; Zuntini R; Amato LB; Ferrari S; Martelli AM; Gasparre G; Turchetti D
BMC Cancer; 2014 Feb; 14():70. PubMed ID: 24498881
[TBL] [Abstract][Full Text] [Related]
25. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
[TBL] [Abstract][Full Text] [Related]
26. MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
Nadler M; Al-Attar H; Warner E; Martel AL; Balasingham S; Zhang L; Lipton JH; Curpen B
Breast; 2017 Aug; 34():77-82. PubMed ID: 28527397
[TBL] [Abstract][Full Text] [Related]
27. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
[TBL] [Abstract][Full Text] [Related]
28. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
29. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
31. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
Wang Q; Weisberg E; Zhao JJ
Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925
[TBL] [Abstract][Full Text] [Related]
32. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
[TBL] [Abstract][Full Text] [Related]
33. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
34. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
Ngeow J; Eng C
Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
[TBL] [Abstract][Full Text] [Related]
35. Brain morphological analysis in PTEN hamartoma tumor syndrome.
Shiohama T; Levman J; Vasung L; Takahashi E
Am J Med Genet A; 2020 May; 182(5):1117-1129. PubMed ID: 32162846
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations.
Sabaté JM; Gómez A; Torrubia S; Blancas C; Sánchez G; Alonso MC; Lerma E
Eur Radiol; 2006 Mar; 16(3):702-6. PubMed ID: 16208511
[TBL] [Abstract][Full Text] [Related]
37. The PTEN hamartoma tumor syndrome: how oral clinicians may save lives.
Fardal Ø; Nevland K; Johannessen AC; Vetti HH
Clin Adv Periodontics; 2023 Mar; 13(1):21-26. PubMed ID: 35352876
[TBL] [Abstract][Full Text] [Related]
38. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
[TBL] [Abstract][Full Text] [Related]
39. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal manifestations in PTEN hamartoma tumor syndrome.
D'Ermo G; Genuardi M
Best Pract Res Clin Gastroenterol; 2022; 58-59():101792. PubMed ID: 35988965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
